drugset / Trial / NCT02770664

Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

NCT02770664 ↗

Phase 2 Unknown 100 enrolled LG Life Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the efficacy, Safety and Pharmacokinetics of Intravenous single injection LC28-0126 immediately before Percutaneous Coronary Intervention (PCI) in Patients with ST-segment Elevation Myocardial Infarction (STEMI).

Timeline

Start
2016-04
Primary completion
2018-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject LC28-0126 Unknown — —